Old Web
English
Sign In
Acemap
>
authorDetail
>
Rajendrakumar Hariprasad Jani
Rajendrakumar Hariprasad Jani
Hypertriglyceridemia
Saroglitazar
Diabetes mellitus
Internal medicine
Medicine
3
Papers
130
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A Prospective, Multicentre, Open-Label Single-Arm Exploratory Study to Evaluate Efficacy and Safety of Saroglitazar on Hypertriglyceridemia in HIV Associated Lipodystrophy
2016
PLOS ONE
Alka Deshpande
Harsh Toshniwal
Shashank R. Joshi
Rajendrakumar Hariprasad Jani
Show All
Source
Cite
Save
Citations (6)
A Multicenter, Prospective, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Saroglitazar 2 and 4 mg Compared with Placebo in Type 2 Diabetes Mellitus Patients Having Hypertriglyceridemia Not Controlled with Atorvastatin Therapy (PRESS VI)
2014
Diabetes Technology & Therapeutics
Rajendrakumar Hariprasad Jani
Vikas Pai
Pramod Jha
Gunjan Jariwala
Satinath Mukhopadhyay
Anil Bhansali
Shashank R. Joshi
Show All
Source
Cite
Save
Citations (67)
A Multicenter, Prospective, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Saroglitazar 2 and 4 mg Compared to Pioglitazone 45 mg in Diabetic Dyslipidemia (PRESS V)
2014
Journal of diabetes science and technology
Vikas Pai
A. Paneerselvam
Satinath Mukhopadhyay
Anil Bhansali
Dinesh Kamath
V. Shankar
Dhiraj Gambhire
Rajendrakumar Hariprasad Jani
Shashank R. Joshi
Pankaj Patel
Show All
Source
Cite
Save
Citations (57)
1